Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Xiamen ITG $300 million bonds offering
The 2.15% guaranteed bonds are due 2022
Yonghe HK$1.49 billion IPO
The shares are listed on the HKEX
APx Acquisition Corp. I $172.5 million IPO
We advised the SPAC on its IPO and Nasdaq listing
FirstCash $550 million senior notes offering
The high-yield notes are due 2030
Genesis Growth Tech Acquisition $220 million IPO
The issuer, a SPAC, offered 22,000,000 units which were listed on Nasdaq
Grayscale Investments public company registrations
We advised Grayscale Investments on the public company registration of three digital asset funds
Patrick Industries $258.75 million convertible notes offering
The 1.75% convertible notes are due 2028
Perion Network $180 million follow-on offering
We advised Perion on the offering of ordinary shares
Target Global Acquisition I $200 million IPO
We advised Target Global Acquisition I, a SPAC, on its IPO and Nasdaq listing
Toronto-Dominion Bank $500 million notes offering
The investment-grade senior notes are due 2024